Stem cell tourism “an emerging public health threat”


In an article on the survey results, published in Multiple Sclerosis News Today, report author Wijden Raj, from The Ohio State University calls for the creation of a publicly available national registry where ‘stem cell tourism’ complications must be reported, and the development of guidelines "on how to care for patients who have undergone experimental stem cell procedures with tumor formation".

Raj said that "75% of the physicians indicated that no patient experienced complications" from unapproved stem-cell-based treatments. However, one in four (25%) reported seeing patients who experienced complications, such as infections, MS deterioration and relapse, stroke, meningoencephalitis, sepsis, tumors, hepatitis C, seizures, or spinal cord injury. At least three neurologists had patients who died from unapproved stem cell procedures.

Stem cell tourism is an "emerging public health threat," and the results "demonstrate an alarming number of unreported complications and negative impact to MS patients," Raj said.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

Bahamas stem cell therapy

02 October, 2020

Insolvency for stem cell clinic

Stem cell therapy risks

18 August, 2020

Injuries from stem cell therapy widespread

Inbound travel to Hong Kong

01 May, 2020

Hong Kong open in July, for Chinese tourists

Improving European cross-border healthcare

24 April, 2020

Ensuring timely access to advanced therapies in Europe

Costa Rica promotes stem cell treatment

23 October, 2019

Costa Rica looks to be stem cell treatment destination